✦ LIBER ✦

High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy

✍ Scribed by Ingeborg Fraunholz, Claus Rödel, Luitpold Distel, Marget Rave-Fränk…

Book ID: 120696398
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 375 KB
Volume: 7
Category: Article
ISSN: 1748-717X
DOI: 10.1186/1748-717X-7-88

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Feasibility of postoperative concurrent

Feasibility of postoperative concurrent chemoradiotherapy in Japanese patients with oral squamous cell carcinoma showing high-risk factors for recurrence

✍ Yamada, Shin-ichi; Yanamoto, Souichi; Takahashi, Hidenori; Naruse, Tomofumi; Shi 📂 Article 📅 2015 🏛 Elsevier 🌐 English ⚖ 480 KB

Concurrent chemoradiotherapy followed by

Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors

✍ Yong Bae Kim; Jae Ho Cho; Ki Chang Keum; Chang Geol Lee; Jinsil Seong; Chang Ok 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 225 KB

8043 POSTER ERCC1 Expression Predicts Re

8043 POSTER ERCC1 Expression Predicts Response and Survival in Locally Advanced Cervical Carcinoma Patients Treated With Concurrent Chemoradiotherapy

✍ Lee, H.J.; Liang, Z.L.; Song, E.K.; Yun, H.J.; Kim, S.; Jo, D.Y.; Kim, J.M. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Human papillomavirus DNA load and p16 IN

Human papillomavirus DNA load and p16 INK4a expression predict for local control in patients with anal squamous cell carcinoma treated with chemoradiotherapy

✍ Rödel, Franz; Wieland, Ulrike; Fraunholz, Ingeborg; Kitz, Julia; Rave-Fränk, Mar 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 French ⚖ 528 KB

ERCC1 expression as a prognostic marker

ERCC1 expression as a prognostic marker in N2(+) nonsmall-cell lung cancer patients treated with platinum-based neoadjuvant concurrent chemoradiotherapy

✍ In Gyu Hwang; Myung Ju Ahn; Byeong Bae Park; Yong Chan Ahn; Joungho Han; Seungko 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 2 views

## Abstract ## BACKGROUND. Excision repair cross‐complementation Group 1 (__ERCC1__) overexpression is associated with resistance to cisplatin‐based chemotherapy in patients with nonsmall‐cell lung cancer (NSCLC). A preliminary study also suggested that __ERCC1__ expression is associated with radi

Excision repair cross-complementation gr

Excision repair cross-complementation group 1 expression predicts response and survival in locally advanced cervical carcinoma patients treated with concurrent chemoradiotherapy

✍ Zhe Long Liang; Eun-Kee Song; Young Bok Ko; Na-Ri Lee; Ho-Young Yhim; Heung-Tae 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 346 KB